Optimizing Purchased Services Post-COVID

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $49.00

CEC Hours: 1

Order Webinar

  

 

With the emergence of the COVID-19 pandemic, business continuity became a matter of survival for many hospitals across the country and thrust supply chain to the center of boardroom-level focus. Underpinning these conversations are suppliers and third-party services, which play an indelible role in the evolving response. This webinar will cover the role that purchased services providers will continue to serve, and where supply chain holds opportunities to optimize supplier agreements to improve department transparency and relationship ownership. Stakeholders tend to own the business relationships with purchased services providers; however, this creates challenges for the supply chain to optimize category spend given a disparate approach.

 

Learning Objectives:

  • Discuss the role of purchased services during COVID-19 and the renewed importance on supplier relationships
  • Consider how stringent category planning can help you build a case for supplier resiliency within your own institution
  • List two reasons why should you prioritize value over price when purchasing services

 

Speakers:

  • Anna Ormiston, Sr. Director, Strategic Sourcing & Data, Conductiv
  • Nicole Barker, RN, Customer Success and Member Engagement, Conductiv

Sponsored By

This webinar is sponsored by AHRMM’s CQO Movement Sponsor:

Premier Logo

Related Resources

Webcast
Get introduced to risk sharing in health care and learn how providers and suppliers can work together to generate financial, operational and clinic
Webcast
Discover tips that can separate a health system’s success or failure when creating a viable purchased services sourcing program in this short AHRMM
Supply Chain Strategies & Solutions Article
Collecting and analyzing data has been a top priority for the healthcare supply chain in recent years.
Supply Chain Strategies & Solutions Article
Webcast
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and